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Abstract
Procedures involving phlebotomy are critical for obtaining diagnostic blood specimens and represent a well known and recognized problem, pro-
bably among the most important issues in laboratory medicine. The aim of this report is to show spurious hyperkalemia and hypocalcemia due to 
inadequate phlebotomy procedure. The diagnostic blood specimens were collected from a male outpatient 45 years old, with no clinical complaints. 
The tubes drawing order were as follows: i) clot activator and gel separator (serum vacuum tube), ii) K3EDTA, iii) a needleless blood gas dedicated-
syringe with 80 I.U. lithium heparin, directly connected to the vacuum tube holder system. The laboratory testing results from serum vacuum tube 
and dedicated syringe were 4.8 and 8.5 mmol/L for potassium, 2.36 and 1.48 mmol/L for total calcium, respectively. Moreover 0.15 mmol/L of free 
calcium was observed in dedicated syringe. A new blood collection was performed without K3EDTA tube. Diff erent results were found for potassi-
um (4.7 and 4.5 mmol/L) and total calcium (2.37 and 2.38 mmol/L) from serum vacuum tube and dedicated syringe, respectively. Also free calcium 
showed diff erent concentration (1.21 mmol/L) in this new sample when compared with the fi rst blood specimen. Based on this case we do not enco-
urage the laboratory managers training the phlebotomists to insert the dedicated syringes in needle-holder system at the end of all vacuum tubes. 
To avoid double vein puncture the dedicated syringe for free calcium determination should be inserted immediately after serum tubes before EDTA 
vacuum tubes.
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The preanalytical phase (PP) is nowadays recog-
nized as the most vulnerable part of the total test-
ing process (1). The PP procedures involving phle-
botomy are critical for obtaining diagnostic blood 
specimens: on the whole they represent a well 
known and recognized problem, probably among 
the most important issues in laboratory medicine 
(2-5). Lippi and Simundic recently advised to think 
outside the box and to address the extra-analytical 
processes that are more vulnerable to errors (6). 
With this aim, we demonstrate here that incorrect 
procedures during phlebotomy can be a source of 
spurious hyperkalaemia and hypocalcemia in pa-
tients’ samples.
Case report
A 45 years old male outpatient, with no apparent 
clinical complaints, wheelchair dependent, calls to 
our laboratory accredited by DICQ® (DICQ is a Na-
tional System of Accreditation from Brazilian Soci-
ety of Clinical Analyses based on ISO 15189 docu-
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ment), asking for a blood specimen collection at 
home, for performing a series of routine laborato-
ry tests prescribed by his physician. The tests are 
the: total cholesterol (CHOL), HDL-cholesterol 
(HDL), triglycerides (TG), sodium (Na), potassium 
(K), total calcium (tCa), free calcium (fCa), urea, cre-
atinine (CREA), total protein (TP), albumin (ALB), al-
kaline phosphatase (ALP) and routine blood count 
with platelets (CBC). The patient was asked to ob-
serve 12-hours overnight fasting and the blood 
collection was scheduled for 7 am, 3 work days af-
ter his call. Before blood collection, the median cu-
bital vein was located on the left forearm using 
only a subcutaneous tissue transilluminator device 
(Venoscópio IV plus, Duan do Brasil, Sao Paulo, Bra-
zil) –without tourniquet – to prevent interference 
from venous stasis (7-9), and blood samples were 
collected using a 20-G straight needle (BD Vacun-
tainer ® Becton, Dickinson and Company Franklin 
Lakes, NJ, USA) connected to the holder, directly 
into the vacuum tubes (Greiner Bio-One GmbH, 
Kremsmünster, Austria). The order of diff erent 
types of tube fi lling was: a) clot activator and gel 
separator tube, b) K3EDTA tube for CBC and c) a 
blood gas dedicated-syringe (Pico 50® with 80 I.U. 
lyophilized electrolyte-balanced lithium heparin, 
Radiometer Medical ApS, Denmark) without nee-
dle, which was directly connected to the needle-
holder system in order to avoid double vein punc-
ture. After collection, the tubes were properly 
mixed and transported from patient’s house to the 
core laboratory by car at 20 ± 2 °C in upright posi-
tion inside a transport box. The blood into syringe 
was transported at 4 ± 1 °C, as recommended by 
clinical laboratory standard institute C31-A2 docu-
ment (10). The blood specimens (serum tube, cell 
blood count tube and dedicated syringe) arrived 
in core laboratory about one hour after blood col-
lection and were immediately processed and ana-
lyzed (< 15 min from the arrival time). The dedicat-
ed syringe was properly mixed and the free calci-
um was measured by ion-selective electrode on 
ABL 700® (Radiometer Medical ApS, Brønshøj, Den-
mark), according to the manufacturer’s specifi ca-
tions and using proprietary reagents. Whole blood 
for CBC was gently mixed and analyzed on Sys-
mex® XE-2100D, Automated Hematology Analyzer 
(Sysmex Corporation®, Kobe, Japan). Serum vacu-
um tube was centrifuged at 1500 x g for 10min at 
room temperature. In sequence, the laboratory 
tests on serum were performed on the primary 
blood tube on Cobas® 6000 < c501 > module (Ro-
che Diagnostics GmbH, Penzberg, Germany), ac-
cording to the manufacturer’s specifi cations and 
using proprietary reagents. All laboratory instru-
ments had been previously calibrated against ap-
propriate proprietary reference standard material 
and verifi ed with the use of proprietary controls. 
Our evaluation of the within-run precision by in-
ternal quality control is shown as coeffi  cients of 
variation (CVa). The results are shown in table 1. 
The laboratory staff  (clinical chemistry specialist) 
contacted the patient by phone because some re-
sults (i.e. potassium, total calcium and free calci-
um) of the sample collected in dedicated syringe 
were out of the critical limits established by Kost 
(11,12). The patient reported that he did not use 
topical medicines or intravenous solution in the 
last four months. A new blood collection (serum 
tube and dedicated syringe only) was scheduled 
for 12.30 pm of the same day. The venipuncture 
for the 2nd blood collection was performed, by the 
same phlebotomist, in cephalic vein on the left 
forearm. The drawing order was: a) clot activator 
and gel separator tube, b) blood gas dedicated-sy-
ringe; both of the same brand and lot used for the 
fi rst blood collection. So, during the 2nd venipunc-
ture the diagnostic blood specimen collection did 
not include a new EDTA vacuum tube. The follow-
ing procedures were identical to the described 
above for the 1st blood specimen collection. The 
2nd blood specimens arrived in core laboratory 
about 45 min after collection and were immedi-
ately processed and analyzed on the same analyti-
cal instruments. The results are shown in table 1.
Statistical analysis
The reference change values (RCV) were determi-
ned to ascertain any clinically signifi cant diff eren-
ces between the fi rst and the second blood collec-
tion according to the formula RCV = 21/2 x Z x 
[(CVa)2 + (CVw)2]1/2 where Z: z-score is 1.96 (5% 
standard normal deviation in bicaudal testing); 
CVa: analytical within run precision of the internal 
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quality control and CVw: coeffi  cient of variation 
within-subject (13) were applied. Mean % diff er-
ences were determined according to the formula 
diff erence % mean = [(1st blood collection – 2nd 
blood collection)/1st blood collection] x 100.
Discussion
In clinical laboratory the quality indicators are fun-
damental tools for quantifying the quality of a se-
lected aspect of care by comparing it against a de-
fi ned goal. For private laboratories the level of pa-
tient satisfaction with the diagnostic blood collec-
tion service is a very important quality indicator. 
With the aim to increase the patient satisfaction 
the procedure described above was implemented 
approximately six months ago in our laboratory, in 
order to avoid double venipuncture. This proce-
dure is not explicitly stated in both international 
and national guidelines but is frequently per-
formed in laboratories of South America countries. 
In order to avoid possible test result errors due to 
additive carryover, the correct order of blood 
drawing by venipuncture should be as follows: i) 
blood culture tube or tube without additive; ii) so-
dium citrate tube; iii) serum tube with or without 
clot activator and with or without gel separator; iv) 
heparin tube with or without gel separator and/or 
dedicated-syringe with heparin; v) EDTA tube with 
or without gel separator; and vi) glycolytic inhibi-
tor tube. The Clinical Laboratory Standard Institute 
H03-A6 document (14) has standardized order of 
draw based on Calam and Cooper results (15). This 
document is widely used by laboratory quality 
managers to standardize the blood collection pro-
cedures (16). When our laboratory employees were 
retrained to eliminate this non conformity, regard-
ing draw order, they reported that: “During the 
maneuver to insert the syringe into the adapter of the 
tube holder, sometimes we risk to miss the vein: for 
this reason and thus to avoid repeating venipunc-
tures, we would like to insert the syringe at the end of 
all tubes rather than at mid blood collection.” None-
theless, this patient’s case demonstrates that 
something wrong can still arise from an apparent-
ly standardized procedure of tube order for blood 
drawing. At fi rst sight, when looking at the potas-
sium and calcium critical values from the 1st col-
lected patient’s sample (dedicated-syringe), a main 
hypothesis of such a severe modifi cation of blood 
potassium and calcium could be a chronic kidney 
disease. Obviously this supposition was discarded 
after checking Urea, CREA, TP and ALB results from 
the 1st and 2nd blood collections, thus the condi-
tion of the patient was judged far from critical. Un-
til now two studies agreed in showing that the or-
der of tube drawing did not aff ect routine bio-
chemistry (e.g. potassium, magnesium, alkaline 
phosphatase, and iron), when closed system for 
blood collection from Sarstedt or BD were used 
(17,18). Unfortunately these studies did not meas-
ure the calcium values in serum tubes collected af-
ter EDTA vacuum tubes and/or vacuum tubes pro-
duced by Greiner Bio-One. Moreover we previous-
ly found that diff erent brands of in vitro diagnostic 
devices (e.g. vacuum tubes and syringes) have dif-
ferent performances in routine laboratory tests 
and that changes in the brands can increase labo-
ratory variability (19-23). Future investigations 
should be planned to cover the impact of vacuum 
tubes brands on EDTA carryover. Several others ar-
ticles showed spurious hyperkalaemia and hypoc-
alcemia based on EDTA carryover (24-26). Cornes 
et al. after measuring EDTA in 117 hyperkalaemic 
samples showed that spurious hyperkalaemia due 
to kEDTA contamination was common (about 25% 
of all samples tested). In the 27 patients retested, 
serum potassium was within the reference range 
confi rming the contamination with EDTA (24). In 
the present case we have estimated an EDTA car-
ryover of 0.5 ~ 0.6 mg/mL of blood into the dedi-
cated syringe from the preceding EDTA-containing 
tube. It was predicted by stoichiometric calcula-
tion based on the observed reduction of Ca ions 
and on the molecular mass of EDTA. The estima-
tion is based on the variation of the potassium 
concentration, from the K3EDTA tube to the sy-
ringe, taking into account that a mass concentra-
tion of 1.5 mg of K3EDTA per 1 mL of blood as an 
optimal anticoagulant level is declared (27). The 
K3EDTA carryover is the best hypothesis to justify 
the spurious results found in the dedicated syringe 
from the 1st blood collection. Moreover when look-
ing at total- and free-calcium results the decreased 
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results observed in dedicated syringe appear not 
so proportionally reduced. Theoretically, the total 
amount of calcium in plasma is about 2.5 mmol/L 
and the normal amount of calcium in plasma that 
can be complexed by a sequestering agent is 1.15 
mmol/L. The remaining calcium is bound to pro-
tein (e.g. albumin) and is scarcely available for se-
questration by EDTA (27). In any case clinically sig-
nifi cant diff erences were observed for potassium, 
total calcium and free calcium only in the blood of 
the dedicated syringe when mean percent diff er-
ences were compared with RCV derived from bio-
logical variation (Table 1) (28). Obviously the quali-
ty specifi cations derived from biological variation 
are considered both very important and useful in 
the daily practice by the quality managers of the 
medical laboratories (13,29,30). Based on this de-
pictive case we recommend the laboratory man-
agers to train the phlebotomists as follows: 1) the 
dedicated needleless syringes for blood-gas must 
be connected to the needle-holder system imme-
diately after serum tubes and before EDTA vacuum 
tubes; 2) to avoid double vein puncture the dedi-
cated needleless syringes for free calcium deter-
mination must be connected to the needle-holder 
system immediately after serum tubes and before 
EDTA vacuum tubes.
In conclusion, we caution the laboratory managers 
about the current procedures advising to connect 
the syringes for blood gas and calcium tests at the 
end of all vacuum tubes; moreover we claim that 






1st blood collection 2nd blood collection Mean % diff erence
















(mmol/L) 4.22-7.12 NA 4.48 - 4.50 - -0.44 - 15.69 1.7 5.4
HDL-cholesterol 
(mmol/L) 0.78-1.66 NA 1.04 - 1.03 - 0.96 - 22.73 4.1 7.1
Triglycerides 
(mmol/L) 0.64-3.16 NA 3.63 - 3.60 - 0.83 - 58.17 1.9 20.9
Sodium 
(mmol/L) 136-145 120/160 138 138 139 139 -0.72 -0.72 3.16 0.9 0.7
Potassium 
(mmol/L) 3.5-5.1 2.8/6.2 4.8 8.5 4.7 4.5 2.08 47.06 13.86 1.4 4.8
Total calcium 
(mmol/L) 2.15-2.55 1.50/3.25 2.36 1.48 2.37 2.38 -0.42 -60.81 5.42 0.6 1.9
Free calcium 
(mmol/L) 1.15-1.33 0.75/1.60 - 0.15 - 1.21 - -706.67 5.00 0.6 1.7
Urea (mmol/L) 2.1-7.1 NA/28.6 5.3 - 5.2 - 1.89 - 34.79 2.5 12.3
Creatinine 
(μmol/L) 80-115 NA/442 84 - 85 - -1.19 - 17.91 2.4 6.0
Total protein 
(g/L) 64-83 NA 78 - 77 - 1.28 - 8.08 1.1 2.7




0.71-1.67 NA 1.28 - 1.26 - 1.56 - 19.04 2.5 6.4
Bold values are results outside of critical limits (11,12) and bold mean % diff erences represent clinically signifi cant variations, when 
compared with reference change value (RCV).
NA - not applied; CVa - analytical within run precision of the internal quality control, CVw - coeffi  cient of variation within-subject (13).
TABLE 1. Laboratory results.
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of all the laboratory staff  with regards to the ef-
fects of preanalytical interferences is a mandatory 
task in every modern clinical laboratory.
Potential confl ict of interest
None declared.
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